Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial

Authors: Yiming Mu, Xiao-lei Bao, Freddy G. Eliaschewitz, Morten Hansen, Bom Taeck Kim, Anna Koroleva, Ronald C.W., Tao Yang, Ning Zu, Ming Liu - The Lancet 2024 cited by 114